Jeon, I., Lee, J., Shin, K., Kang, T., Park, M. H., Seo, H., . . . Kang, C. (2020). Enhanced Immunogenicity of Engineered HER2 Antigens Potentiates Antitumor Immune Responses. Vaccines (Basel).
Chicago-tyylinen lähdeviittausJeon, Insu, et al. "Enhanced Immunogenicity of Engineered HER2 Antigens Potentiates Antitumor Immune Responses." Vaccines (Basel) 2020.
MLA-viiteJeon, Insu, et al. "Enhanced Immunogenicity of Engineered HER2 Antigens Potentiates Antitumor Immune Responses." Vaccines (Basel) 2020.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.